Trade of the House

← All trades

SELL SYK · Thomas H. Kean Jr

Stryker Corporation Common Stock (SYK)

B

Deliberate position with a committee link

Signal score 63 / 100 — how much this looks like a deliberate, informed position rather than routine portfolio activity.
Inside their committee's jurisdiction
32/32
Isolated decision, not a bulk rebalance
21/22
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
2/10
Member's own account
8/8
Committee chair or ranking member
0/8
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
0/8
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
0/6
Position size
0/3
Leveraged instrument (option)
0/3

A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.

It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.

The filing it came from

filed in 27 days Within the 30-day notification window.

No matching purchase on file. This member has no earlier disclosed purchase of SYK in this account, so the position was almost certainly opened before these records begin in 2019. About 45% of sales are in this situation.

This is a sale, and the strategy does not act on it. It records the member closing a position; it is not a short signal and not an instruction to sell. Exiting when members disclose selling, rather than at twelve months, cut in-remit alpha from +4.75% to +2.83% — a cost of 3.91 points on the trades it changed. See the method.

This filing disclosed 6 transactions in total, of which 2 share this trade date (22 Jul 2026).

Few other trades share this date, so this reads as a discrete decision rather than a portfolio sweep.

Filed 18 Aug 2026 · source PDF

Same day: GOOGL

Price

Entry
Latest
$339.98
19 Aug 2026
Since entry
price only

52-week range $281.83 – $390.37. The marker is the entry: the first market open after this filing became public.

Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care di…

Market cap
$130.4B
1yr target
$383
+12.6% from $339.98
Analysts
25
buy
P/E
35.3
beta 0.77
SectorHealthcare
IndustryMedical Devices
Analyst range $315 – $465
Employees56,000
InstrumentST
Jurisdiction tags healthcare

https://www.stryker.com

Inside this member's remit. Their committees cover defenseenergyhealthcaretechnologytelecom

Expressing this with options

An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.

Loading chain…

Outcome

HeldThis tradeS&P 500Alpha
1m
3m
6m
12m 1yr
18m
24m
36m
48m
60m 5yr

Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. The last 9 rows are blank because those windows have not closed yet: this trade was entered —, so anything longer than that is still running.

Other congressional trades in SYK

GradeDateMemberSideAmount
C 02 Jun 2026 Thomas H. Kean Jr sale partial $1,001 - $15,000
E 27 Mar 2026 Alan Armstrong sale $15,001 - $50,000
B 23 Jan 2026 Thomas H. Kean Jr sale partial $15,001 - $50,000
E 10 Dec 2025 Gilbert Cisneros purchase $1,001 - $15,000
B 20 Nov 2025 Thomas H. Kean Jr sale partial $15,001 - $50,000
E 18 Nov 2025 Gilbert Cisneros purchase $1,001 - $15,000
E 17 Oct 2025 Gilbert Cisneros purchase $1,001 - $15,000
B 16 Oct 2025 Julia Letlow sale $1,001 - $15,000
B 12 Sep 2025 Thomas H. Kean Jr sale partial $15,001 - $50,000
B 25 Aug 2025 Thomas H. Kean Jr sale partial $1,001 - $15,000
B 31 Jul 2025 Thomas H. Kean Jr sale partial $15,001 - $50,000
B 26 Jun 2025 Thomas H. Kean Jr sale partial $15,001 - $50,000
E 12 May 2025 Jefferson Shreve sale $50,001 - $100,000
E 17 Apr 2025 Jefferson Shreve purchase $15,001 - $50,000
E 08 Apr 2025 Rob Bresnahan sale $1,001 - $15,000
E 08 Apr 2025 Rob Bresnahan sale $1,001 - $15,000
E 07 Apr 2025 Julie Johnson sale $1,001 - $15,000
E 07 Apr 2025 Jared Moskowitz purchase $1,001 - $15,000
E 13 Mar 2025 Jefferson Shreve sale partial $50,001 - $100,000
B 26 Feb 2025 Thomas H. Kean Jr sale partial $15,001 - $50,000
E 15 Jan 2025 Jared Moskowitz purchase $1,001 - $15,000
E 15 Jan 2025 Jared Moskowitz purchase $1,001 - $15,000
C 23 Oct 2024 Julia Letlow purchase $1,001 - $15,000
E 24 Oct 2023 Greg Stanton sale $1,001 - $15,000
E 26 Sep 2023 Greg Stanton purchase $1,001 - $15,000